For us, M&As are about calibrated aggression: Ramesh Swaminathan, CFO of Lupin 
Mumbai-based Lupin Ltd is the second-largest pharma company in the country by market capitalisation behind Sun Pharma. It is dominant in the anti-TB and cephalosporin segment but is also a significant...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
- Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
- Daily, weekly and monthly curated newsletters on the deal ecosystem in India
- Breaking news alerts
- Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced
Leave Your Comment(s)
